Halozyme Therapeutics (HALO) AGM 2026 summary

Opening remarks and agenda

• Meeting called to order with voting and Q&A instructions provided to shareholders.

• Mark Snyder appointed as secretary and Inspector of Elections; board members and auditors introduced.

• Quorum established with 104.1 million shares represented, authorizing business transactions.

• Agenda included election of two Class I directors, advisory vote on executive compensation, and ratification of the auditor.

Board and executive committee updates

• Bernadette Connaughton and Matthew Posard elected as Class I directors for a three-year term.

• Special thanks extended to outgoing board member Moni Miyashita for her contributions.

Shareholder proposals

• Advisory vote approved executive compensation.

• Ratification of Ernst & Young LLP as independent auditor for fiscal year ending December 31, 2026.